Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type One Diabetes Mellitus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00601250
What this trial is testing

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 701
Not applicableUnknownNCT05673837
What this trial is testing

The Type ONe dIabetic Bone Collaboration Study

Who this might be right for
Osteoporosis SecondaryDiabetes Mellitus, Type 1
Odense University Hospital 148
Not applicableUnknownNCT03459573
What this trial is testing

Fit-One: A Trial Evaluating the Effect of One Drop and Fitbit on Diabetes and Pre-diabetes Outcomes

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1PreDiabetes
Chandra Osborn, PhD, MPH 500
Not applicableUnknownNCT04627402
What this trial is testing

Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)

Who this might be right for
Diabetes Mellitus, Type 2Macular Edema
Zhongshan Ophthalmic Center, Sun Yat-sen University 50
Not applicableEnded earlyNCT00870831
What this trial is testing

Islet Function and Clinical Analyses of Transplant Recipients

Who this might be right for
Type One Diabetes Mellitus
Washington University School of Medicine 8
Early research (Phase 1)Ended earlyNCT01488877
What this trial is testing

Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

Who this might be right for
Type 2 Diabetic Nephropathy
Pfizer 6
Large-scale testing (Phase 3)Study completedNCT06871761
What this trial is testing

A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes

Who this might be right for
Adult Patients With Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 393
Large-scale testing (Phase 3)Study completedNCT02073188
What this trial is testing

Comparative Study of a Smartphone-Linked Self-Monitoring System Versus a Traditional One for Improving Metabolic Control and Compliance to Self-Monitoring of Blood Glucose

Who this might be right for
Diabetes Mellitus
Sanofi 186
Not applicableStudy completedNCT02839174
What this trial is testing

Type One Diabetes and Low Carb Study

Who this might be right for
Diabetes Mellitus, Type 1
Boston Children's Hospital 340
Not applicableStudy completedNCT05811078
What this trial is testing

Metabolic Control Adolescents Type 1 Diabetes

Who this might be right for
13-18 YearDiagnosed at Least 6 Months AgoHbA1C> 7.5+1 more
Toros University 46
Not applicableStudy completedNCT06254339
What this trial is testing

Effects of OAGB and DJB-SG on 10-year and Lifetime Risks of MACE

Who this might be right for
Obesity
National Defense Medical Center, Taiwan 830
Testing effectiveness (Phase 2)Active Not RecruitingNCT02081326
What this trial is testing

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type OneDiabetes Mellitus, Type IAutoimmune Diabetes+1 more
Massachusetts General Hospital 150
Large-scale testing (Phase 3)Not Yet RecruitingNCT06731075
What this trial is testing

Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Type 2 Diabetes Mellitus
Oramed, Ltd. 300
Post-approval studies (Phase 4)Study completedNCT00036504
What this trial is testing

Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 100
Not applicableStudy completedNCT01330121
What this trial is testing

Bridging the Gap by Transitional Care

Who this might be right for
Diabetes Mellitus Type 2
Cook County Health 130
Large-scale testing (Phase 3)Study completedNCT03767543
What this trial is testing

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 265
Post-approval studies (Phase 4)Study completedNCT00965549
What this trial is testing

Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 463
Post-approval studies (Phase 4)Study completedNCT00384085
What this trial is testing

Insulin Glargine "All to Target" Trial

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 588
Large-scale testing (Phase 3)Study completedNCT00150410
What this trial is testing

Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose

Who this might be right for
Diabetes Mellitus
Pfizer 626
Not applicableUnknownNCT04100070
What this trial is testing

Intensive Versus Standard One Year Monitoring on Glycaemic Control After Initiating CSII in Children With DT1. DEEP Study

Who this might be right for
Diabetes Mellitus, Type 1Pediatric ALL
ISIS Diabete Service 320
Next Page